AQEMIA
Aqemia is a next-gen pharmatech company generating one of the world's fastest-growing drug discovery pipeline. Our mission is to design fast innovative drug candidates for dozens of critical diseases. What sets us apart is our unique quantum and statistical mechanics algorithms fuelling a generative AI to design novel drug candidates. The disruptive speed and accuracy of our technology platform allows us to scale drug discovery projects as technology projects.
AQEMIA
Industry:
Artificial Intelligence (AI) Biotechnology Generative AI Life Science Machine Learning Pharmaceutical
Founded:
2019-06-13
Address:
Paris, Ile-de-France, France
Country:
France
Website Url:
http://www.aqemia.com
Total Employee:
51+
Status:
Active
Total Funding:
60.1 M EUR
Technology used in webpage:
Domain Not Resolving Amazon HSTS Amazon Virginia Region Amazon Elastic Load Balancing Amazon ELB North Virginia Amazon Elastic Beanstalk
Similar Organizations
Coriell Life Sciences
Coriell Life Sciences delivers the power of precision medicine using pharmacogenomics and clinical decision support software.
Iroko Pharmaceuticals
Iroko Pharmaceuticals is a global specialty pharmaceutical company dedicated to advancing the science of analgesia.
Deepbrain AI
Deepbrain AI provides a range of AI powered customer service products.
Navrogen
Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.
Pera Labs
Pera Labs develops digiceuticals and AI-powered solutions for fertility.
Proscia
Proscia develops a pathology platform to assist routine pathology operations, enhance cancer diagnosis, and improve patient outcomes.
Valohai
Valohai develops a MLOps platform designed for ML pioneers.
Current Employees Featured
Founder
Investors List
Bpifrance
Bpifrance investment in Series A - AQEMIA
Eurazeo
Eurazeo investment in Series A - AQEMIA
Elaia
Elaia investment in Series A - AQEMIA
Wendel Growth
Wendel Growth investment in Series A - AQEMIA
Eurazeo
Eurazeo investment in Series A - AQEMIA
Bpifrance
Bpifrance investment in Series A - AQEMIA
Elaia
Elaia investment in Series A - AQEMIA
Elaia
Elaia investment in Series A - AQEMIA
Eurazeo
Eurazeo investment in Series A - AQEMIA
Elaia
Elaia investment in Pre Seed Round - AQEMIA
Official Site Inspections
http://www.aqemia.com Semrush global rank: 6.95 M Semrush visits lastest month: 965
- Host name: 198.49.23.145
- IP address: 198.49.23.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "AQEMIA"
AQEMIA - Crunchbase Company Profile & Funding
AQEMIA raised €60M in Series A funding to accelerate its proprietary therapeutic pipeline. Additionally, AQEMIA achieved a research milestone against an undruggable target in immuno-oncology in collaboration with Servier. View …See details»
AQEMIA Company Profile 2024: Valuation, Funding & Investors
Developer of a drug discovery platform designed to discover new drugs for specific therapeutic targets.See details»
AQEMIA - LinkedIn
AQEMIA is a next-gen pharmatech company generating one of the world's fastest-growing drug discovery pipeline. Our mission is to design fast innovative drug candidates for dozens of critical diseases, such as immuno-oncology.See details»
Aqemia - Overview, News & Similar companies | ZoomInfo.com
Jun 13, 2024 Who is Aqemia. AQEMIA is a next-gen pharmatech company generating one of the world's fastest-growing drug discovery pipeline. Our mission is to design fast innova tive …See details»
Aqemia - Company Profile - Tracxn
Oct 31, 2024 Aqemia ranks 1st among 44 active competitors. 20 of its competitors are funded while 3 have exited. Overall, Aqemia and its competitors have raised over $460M in funding …See details»
AQEMIA Boosts Series A Funding to 60M to Accelerate on its
Organization that embraces generative AI and rigorous physics as key instruments to bring excellence in small molecule drug discovery.”, said ... founder of AQEMIA. About AQEMIA …See details»
Aqemia - Products, Competitors, Financials, Employees, …
Aqemia serves as a pharma tech company that focuses on transforming the drug discovery process. Its main service is leveraging technology that combines quantum-inspired physics …See details»
Aqemia Company Profile - Office Locations, Competitors, Revenue …
See insights on Aqemia including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Aqemia - Org Chart, Teams, Culture & Jobs - The Org
View Aqemia's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
AQEMIA - Updates, News, Events, Signals & Triggers - Crunchbase
Organization. AQEMIA . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Growth Insight Details. Powered by AI . Edit Growth …See details»
Aqemia – Elaia
Aqemia raises €30 million in a Series A funding round led by Eurazeo and Bpifrance through its Large Venture fund, with the participation of Elaia its historic investor. This financing will …See details»
AQEMIA Boosts Series A Funding to €60M to Accelerate on its …
PARIS, January 30, 2024--AQEMIA continues to grow rapidly in its effort to discover new drugs with their generative-AI fueled by deep physics. After raising €30M last year, the tech-enabled …See details»
Careers - Aqemia
At Aqemia you will work in a multi-disciplinary team of passionate drug hunters, AI engineers and developers who are committed to our mission of finding many drugs, at high pace, to cure …See details»
Aqemia wins $32.5m for generative AI-powered drug discovery …
Jan 30, 2024 Paris-based biotech Aqemia has secured €30m ($32.5m) in Series A funding to advance its generative artificial intelligence (AI)-led drug pipeline. The company previously …See details»
☑️Aqemia — Consulting Organization from France
Aqemia — Consulting Organization from France with 11-50 employees, has experience with Horizon Europe (2021 - 2027), it`s involved in Health, Laboratory & Measurement, Research, …See details»
Aqemia - EU-Startups
Articles about Aqemia: September 10, 2024 Cambridge-based CardiaTec raises €5.8 million for computational cardiovascular drug discovery platform; February 2, 2024 Weekly funding round …See details»
Sanofi’s $140 million investment in Aqemia will accelerate drug ...
Dec 12, 2023 Aqemia’s streamlined technology is poised to contribute to the development of superior pharmaceuticals at an unprecedented pace. By combining physics algorithms and …See details»
AQEMIA Announces a Major Multi-year Collaboration of $140 …
Dec 5, 2023 AQEMIA is a next-gen pharmatech company generating one of the world's fastest-growing drug discovery pipeline. Our mission is to design fast innovative drug candidates for …See details»
AQEMIA - Medium
Feb 21, 2022 Aqemia is a next-gen pharmatech company generating one of the world’s fastest-growing drug discovery pipeline thanks to our unique quantum and statistical mechanics …See details»